AbD Serotec, UCLB Ink Deal For PTH Diagnostic Antibody
The anti-PTH antibody forms the basis of an existing relationship between AbD Serotec and a diagnostic company which markets clinical parathyroid hormone assays. PTH is the regulator of
Faeth Therapeutics has received the US Food and Drug Administration’s (FDA) fast track designation for the sapanisertib and serabelisib (PIKTOR) with paclitaxel combination to treat advanced or recurrent endometrial cancer.